Aldosterone Dysregulation With Aging Predicts Renal Vascular Function and Cardiovascular Risk

No abstract is available for this paper.

• Publication year

  2014

• Venue

  HYPERTENSION

• Publication date

  2014-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/HYPERTENSIONAHA.114.03231PMID 24664291PMCID PMC4016103
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Abnormal Aldosterone Physiology and Cardiometabolic Risk Factors

  2013influential reference
• Nonmodulation as the mechanism for salt sensitivity of blood pressure in individuals with hypertension and type 2 diabetes mellitus.

  2012cited by this paper
• Vitamin D3 therapy corrects the tissue sensitivity to angiotensin ii akin to the action of a converting enzyme inhibitor in obese hypertensives: an interventional study.

  2012influential reference
• The association of plasma resistin with dietary sodium manipulation, the renin‐angiotensin‐aldosterone system, and 25‐Hydroxyvitamin D3 in human hypertension

  2011cited by this paper
• Plasma aldosterone levels and aldosterone-to-renin ratios are associated with endothelial dysfunction in young to middle-aged subjects.

  2011cited by this paper
• Plasma aldosterone levels are associated with increased cardiovascular mortality: the Ludwigshafen Risk and Cardiovascular Health (LURIC) study.

  2010cited by this paper
• Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60 mL/min/1.73 m2.

  2010cited by this paper
• Trends in 24-h urinary sodium excretion in the United States, 1957-2003: a systematic review.

  2010cited by this paper
• A new equation to estimate glomerular filtration rate.

  2009cited by this paper
• Primary aldosteronism: cardiovascular, renal and metabolic implications.

  2008cited by this paper
• Aldosterone as a Cardiovascular Risk Factor

  2007cited by this paper
• Body mass index predicts aldosterone production in normotensive adults on a high-salt diet.

  2007cited by this paper
• Aldosterone as a cardiovascular risk hormone.

  2007cited by this paper
• Long-term renal outcomes in patients with primary aldosteronism.

  2006cited by this paper
• Selective aldosterone blockade with eplerenone reduces albuminuria in patients with type 2 diabetes.

  2006cited by this paper
• Aldosterone blockade: an emerging strategy for abrogating progressive renal disease.

  2006cited by this paper
• Double-blind, placebo-controlled study on the effect of the aldosterone receptor antagonist spironolactone in patients who have persistent proteinuria and are on long-term angiotensin-converting enzyme inhibitor therapy, with or without an angiotensin II receptor blocker.

  2006cited by this paper
• Beneficial impact of spironolactone in diabetic nephropathy.

  2005cited by this paper
• Aldosterone as a cardiovascular risk factor.

  2005cited by this paper
• Beneficial effects of adding spironolactone to recommended antihypertensive treatment in diabetic nephropathy: a randomized, double-masked, cross-over study.

  2005cited by this paper
• Serum aldosterone and the incidence of hypertension in nonhypertensive persons.

  2004cited by this paper
• The effect of spironolactone, cilazapril and their combination on albuminuria in patients with hypertension and diabetic nephropathy is independent of blood pressure reduction: a randomized controlled study

  2004cited by this paper
• Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.

  2003cited by this paper
• Hypertension and Left Ventricular Hypertrophy : The 4 E Effects of Eplerenone , Enalapril , and Eplerenone / Enalapril in Patients With Essential

  2003cited by this paper
• Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats.

  2003cited by this paper
• EPLERENONE POST-ACUTE MYOCARDIAL INFARCTION HEART FAILURE EFFICACY AND SURVIVAL STUDY INVESTIGATORS. EPLERENONE, A SELECTIVE ALDOSTERONE BLOCKER, IN PATIENTS WITH LEFT VENTRICULAR DYSFUNCTION AFTER MYOCARDIAL INFARCTION

  2003cited by this paper
• Aldosterone induces a vascular inflammatory phenotype in the rat heart.

  2002cited by this paper
• Aldosterone-induced inflammation in the rat heart : role of oxidative stress.

  2002cited by this paper
• Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation.

  2001cited by this paper
• The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure

  2000cited by this paper
• Aldosterone and vascular damage

  2000cited by this paper
• Aldosterone: a mediator of myocardial necrosis and renal arteriopathy.

  2000cited by this paper
• A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation

  1999cited by this paper
• Cardiovascular complications in patients with primary aldosteronism.

  1999cited by this paper
• Relationship between insulin resistance and nonmodulating hypertension: linkage of metabolic abnormalities and cardiovascular risk.

  1999cited by this paper
• The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.

  1999cited by this paper
• Prediction of coronary heart disease using risk factor categories.

  1998cited by this paper
• Anatomic and physiologic age changes in the kidney.

  1986cited by this paper
• Correction of abnormal renal blood flow response to angiotensin II by converting enzyme inhibition in essential hypertensives.

  1985cited by this paper
• Defect in the sodium-modulated tissue responsiveness to angiotensin II in essential hypertension.

  1983cited by this paper
• Aging and aldosterone.

  1983cited by this paper
• Effect on aging on plasma renin and aldosterone in normal man.

  1975cited by this paper
• Printed in U.S.A. Copyright © 2000 by The Endocrine Society Aldosterone: A Mediator of Myocardial Necrosis and Renal Arteriopathy*

  year unknowncited by this paper

• Effect of baxdrostat on ambulatory blood pressure in patients with resistant hypertension (Bax24): a phase 3, randomised, double-blind, placebo-controlled trial.

  2026cites this paper
• No Evidence of QTc Interval Prolongation With Baxdrostat Treatment: Concentration–QTc Modeling Assessment

  2025cites this paper
• Risk of Hypertension and Chronic Kidney Disease Following Aldosterone Dysregulation

  2025cites this paper
• Rethinking Primary Aldosteronism: The 2025 John H. Laragh Research Award.

  2025cites this paper
• Baxdrostat Efficacy and Safety in Uncontrolled and Resistant Hypertension

  2025cites this paper
• Baxdrostat for uncontrolled and resistant hypertension: rationale and design of the Phase 3 clinical trials BaxHTN, BaxAsia, and Bax24

  2025cites this paper
• Elucidating emerging signaling pathways driving endothelial dysfunction in cardiovascular aging.

  2025cites this paper
• Subclinical Primary Aldosteronism and Major Adverse Cardiovascular Events: A Longitudinal Population-Based Cohort Study.

  2025cites this paper
• Practical consensus for the treatment and follow-up of primary aldosteronism: a multidisciplinary consensus document

  2024cites this paper
• Relationship between 24-h Ambulatory Blood Pressure Variability and Degree of Renal Artery Stenosis in Hospitalized Patients with Hypertension

  2024cites this paper
• Potential of Modulating Aldosterone Signaling and Mineralocorticoid Receptor with microRNAs to Attenuate Diabetic Kidney Disease

  2024cites this paper
• Biomarkers to Guide Medical Therapy in Primary Aldosteronism.

  2023cites this paper
• Subclinical Primary Aldosteronism and Cardiovascular Health: A Population-Based Cohort Study

  2023cites this paper
• A low dietary sodium dose is associated with a more pronounced aldosterone response in normotensive than in hypertensive individuals

  2023cites this paper
• Adverse pregnancy outcomes and renal-vascular function in the early years after delivery.

  2023cites this paper
• Elevated Blood Pressure and Aldosterone Dysregulation in Young Black Women versus White Women on Controlled Sodium Diets.

  2023cites this paper
• Sacubitril/valsartan ameliorates renal tubulointerstitial injury through increasing renal plasma flow in a mouse model of type 2 diabetes with aldosterone excess.

  2023cites this paper
• Recalibrating Interpretations of Aldosterone Assays Across the Physiologic Range: Immunoassay and Liquid Chromatography–Tandem Mass Spectrometry Measurements Under Multiple Controlled Conditions

  2022cites this paper
• Primary aldosteronism — a multidimensional syndrome

  2022cites this paper
• Primary Aldosteronism: State-of-the-Art Review.

  2022cites this paper
• Cerebral Hemorrhage: Pathophysiology, Treatment, and Future Directions

  2022cites this paper
• Salt sensitivity of blood pressure and aldosterone: interaction between Lysine-specific demethylase 1 gene, sex, and age.

  2022cites this paper
• Kidney and epigenetic mechanisms of salt-sensitive hypertension

  2021cites this paper
• The role of thyroid in renovascular function: Independent association of serum TSH with renal plasma flow.

  2021cites this paper
• Associations of trauma and posttraumatic stress disorder with aldosterone in women.

  2021cites this paper
• Autonous Aldosterone Secretion as a Subclinical Form of Primary Aldosteronism: Pathogenesis and Clinical Significance.

  2021cites this paper
• Pathophysiology and histopathology of primary aldosteronism.

  2021cites this paper
• Hyperaldosteronism: types, clinical characteristics, and treatment

  2021cites this paper
• miR-196b-5p-enriched extracellular vesicles from tubular epithelial cells mediated aldosterone-induced renal fibrosis in mice with diabetes

  2020cites this paper
• Aldosterone and the mineralocorticoid receptor in renal injury: A potential therapeutic target in feline chronic kidney disease

  2020cites this paper
• Primary aldosteronism in the elderly.

  2020cites this paper
• Interactions of the DASH Diet with the Renin-Angiotensin-Aldosterone System

  2019cites this paper
• Primary Aldosteronism: A Glimpse into the Most Common Endocrine Cause of Arterial Hypertension

  2019cites this paper
• Sex-specific differences in endoplasmic reticulum aminopeptidase 1 modulation influence blood pressure and renin-angiotensin system responses.

  2019influential citation
• Hyperaldosteronism - Endotext - NCBI Bookshelf

  2019cites this paper
• The Expanding Spectrum of Primary Aldosteronism: Implications for Diagnosis, Pathogenesis, and Treatment.

  2018cites this paper
• The Biology of Normal Zona Glomerulosa and Aldosterone-Producing Adenoma: Pathological Implications

  2018cites this paper
• Mechanisms of altered renal sodium handling in age-related hypertension.

  2018cites this paper
• The pivotal role of renal vasodysfunction in salt sensitivity and the initiation of salt-induced hypertension

  2017cites this paper
• Age-Related Autonomous Aldosteronism

  2017cites this paper
• AN INDIVIDUALIZED APPROACH TO THE EVALUATION AND MANAGEMENT OF PRIMARY ALDOSTERONISM.

  2017cites this paper
• The Spectrum of Subclinical Primary Aldosteronism and Incident Hypertension

  2017cites this paper
• Continuum of Renin-Independent Aldosteronism in Normotension

  2017cites this paper
• Dysregulated aldosterone secretion in persons of African descent with endothelin-1 gene variants.

  2017cites this paper
• Treatment with patiromer decreases aldosterone in patients with chronic kidney disease and hyperkalemia on renin-angiotensin system inhibitors.

  2016cites this paper
• Aldosterone-Renin Ratio and Side-Selective Renal Perfusion in Essential Hypertension.

  2016cites this paper
• Local Control of Aldosterone Production and Primary Aldosteronism.

  2016cites this paper
• Dietary Sodium Restriction Increases the Risk of Misinterpreting Mild Cases of Primary Aldosteronism.

  2016cites this paper
• Genetics of primary aldosteronism.

  2015cites this paper
• Aging, arterial stiffness, and hypertension.

  2015cites this paper
• Aldosterone and the Mineralocorticoid Receptor: Risk Factors for Cardiometabolic Disorders

  2015cites this paper
• Vascular biology of ageing—Implications in hypertension

  2015cites this paper
• Mineralocorticoid receptor antagonists for the treatment of hypertension and the metabolic syndrome.

  2015cites this paper
• Genetics of primary aldosteronism.

  2014cites this paper
• Aging , Arterial Stiffness , and Hypertension Zhongjie Sun Recent Advances in Hypertension ( Hypertension

  year unknowncites this paper